Search clinical trials for: EVP

Total 1500 results

Southern Illinois University Edwardsville

Terminated

Effects of Resistance Training on Substrate Metabolism During the Menstrual Cycle

Menstrual Cycle | Substrate Metabolism

United States
Southern Illinois University Edwardsville

Terminated

Effects of Resistance Training in Body Composition and Body Image Perception of Women Throughout the Menstrual Cycle

Body Image Disturbance

United States
Johns Hopkins University

Recruiting

Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)

Pulmonary Arteriovenous Malformation

United States
Fontem Ventures BV

Completed

A Study to Evaluate the Safety of Electronic Vapor Products for 2 Years

Healthy Volunteers

United Kingdom
FORUM Pharmaceuticals Inc

Completed

Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of [18F]MNI-659 by EVP-6308

Healthy

United States
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Focal Muscular Vibration in Patients With Severe Acquired Brain Injury

Brain Injuries | Spasticity, Muscle

Italy
FORUM Pharmaceuticals Inc
Parexel

Completed

Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease

Mild Cognitive Impairment | Alzheimer's Disease

United States
FORUM Pharmaceuticals Inc
PRA Health Sciences

Completed

EVP-6124 Hepatic Impairment Study

Hepatic Impairment

Czech Republic, Poland, Slovakia
FORUM Pharmaceuticals Inc
PRA Health Sciences

Completed

EVP-6124 Renal Impairment Study

Renal Impairment

Czech Republic, Hungary
FORUM Pharmaceuticals Inc

Terminated

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

Dementia | Alzheimer's Disease

United States, United Kingdom, Spain, Canada, Netherlands, Korea, Republic of, Belgium, Poland, South Africa, Czech Republic, Australia, Italy
FORUM Pharmaceuticals Inc

Terminated

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Dementia | Alzheimer's Disease

United States, France, United Kingdom, Spain, Argentina, Canada, Netherlands, Korea, Republic of, Australia, Czech Republic, Germany, Italy, Mexico, South Africa
FORUM Pharmaceuticals Inc

Terminated

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Dementia | Alzheimer's Disease

United States, France, Poland, Spain, Belgium, South Africa, Korea, Republic of, Canada, Germany, Italy, Mexico, Australia
FORUM Pharmaceuticals Inc
INC Research Limited

Completed

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Central Nervous System Diseases | Alzheimer's Disease | Cognition

United States, Romania, Ukraine, Serbia, Russian Federation
NVP Healthcare

Recruiting

To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients

Cardiovascular Diseases

Korea, Republic of
Eagle Vision Pharmaceutical Corp.

Completed

Safety and Efficacy of SeeMore (TM) in Heart Patients

Myocardial Infarction
FORUM Pharmaceuticals Inc
Quintiles, Inc.

Withdrawn

Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine

Dementia | Alzheimer's Disease | Cognition

United States
NVP Healthcare

Completed

Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2 (Navipharm)

Healthy

Korea, Republic of
NVP Healthcare

Completed

Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1805-R1 and NVP-1805-R2

Healthy

Korea, Republic of
NVP Healthcare

Withdrawn

Pharmacokinetic Interaction and Safety/Tolerability Between NVP-1603-1 and NVP-1603-2

Healthy
NVP Healthcare

Completed

Efficacy and Safety of NVP-1203 and NVP-1203-R in Patients With Acute Low Back Pain

Acute Low Back Pain

Korea, Republic of
NVP Healthcare

Completed

Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

Acute Low Back Pain

Korea, Republic of
Codman & Shurtleff

Completed

Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System

Subarachnoid Hemorrhage | Intraventricular Hemorrhage

France, United States, Hong Kong, Canada, United Kingdom, Singapore, China, Norway
NVP Healthcare

Completed

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

Healthy Volunteers

Korea, Republic of
NVP Healthcare

Completed

Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2 (NVP-1805)

Healthy

Korea, Republic of
VA Office of Research and Development

Not yet recruiting

Adapting Treatment Delivery to Improve Retention in Evidence-Based PTSD Treatment

Stress Disorders, Post-Traumatic

United States
Staar Surgical Company

Completed

Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL)

Myopia | Myopic Astigmatism

United States
NVP Healthcare

Completed

Pharmacokinetic Characteristics and Safety After Administration of NVP-2002

Healthy

Korea, Republic of
FORUM Pharmaceuticals Inc
Syneos Health

Completed

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease

Central Nervous System Diseases | Alzheimer's Disease

United States
NVP Healthcare

Completed

NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)

Healthy Volunteers

Korea, Republic of
Utah State University
University of North Carolina, Chapel Hill; International OCD Foundation

Completed

Combining Acceptance and Commitment Therapy With Exposure and Response Prevention to Enhance Treatment Engagement

Obsessive-Compulsive Disorder

United States
NVP Healthcare

Completed

To Evaluate the Safety and the Pharmacokinetics of NVP-2203

Healthy Volunteers

Korea, Republic of
University of Utah
Incyte Corporation

Terminated

Itacitinib (INCB039110) and Extracorporeal Photopheresis (ECP) for First-Line Treatment in Chronic GVHD (FLIGHT)

Chronic Graft-versus-host-disease

United States
Baylor College of Medicine

Withdrawn

Individual Versus Group Exposure With Response Prevention (ERP) for the Treatment of Obsessive Compulsive Disorder (OCD)

OCD

United States
NVP Healthcare

Completed

A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402

Healthy

Korea, Republic of
NVP Healthcare

Completed

Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy Subjects

Healthy Subjects

Korea, Republic of
Mclean Hospital
Utah State University

Completed

Assessing Models of Exposure Therapy

Obsessive-compulsive Disorders and Symptoms

United States
NVP Healthcare

Completed

Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

Healthy Subjects

Korea, Republic of
Evaxion Biotech A/S
Novotech (Australia) Pty Limited

Terminated

Study of Adjuvant Immunotherapy With EVX-02 and Anti-PD-1

Melanoma Stage IV | Melanoma Stage III

Australia
FORUM Pharmaceuticals Inc

Completed

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia

Central Nervous System Diseases | Schizophrenia | Schizoaffective Disorder

United States
GrayMatters Health Ltd.

Recruiting

PRISM Neurofeedback Training for MDD Anhedonic Patients

Depression | Anhedonia

United States
University of North Carolina, Chapel Hill

Completed

One-session Treatment for Spider Fears

Spider Phobia

United States
FORUM Pharmaceuticals Inc

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen in Subjects With Schizophrenia Currently Receiving Stable Treatment With up to 2 Atypical Antipsychotics

Schizophrenia

United States
FORUM Pharmaceuticals Inc
Syneos Health

Completed

A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

Schizophrenia | Impaired Cognition

United States, Ukraine, United Kingdom, Germany, Spain, Argentina, Canada, Singapore, Russian Federation, Italy, Mexico, Colombia, Australia, Belgium, Poland, Romania
The Cooper Health System
NeuroDx Development

Completed

Non-Invasive CVP Method to Standard CVP Method

Central Venous Pressure
University of California, San Diego
University of California, Los Angeles; University of Alabama at Birmingham; National...

Completed

Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke (CUFFS)

Stroke

United States
Jason Martyn
Alberta Health services; University of Alberta; University of Calgary; Physiotherapy...

Unknown

Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care (TPC-RCT)

Bladder Cancer | Nutrition Aspect of Cancer
Butler Hospital
National Institute of Mental Health (NIMH)

Completed

Transcranial Direct Current Stimulation Augmented Exposure and Response Prevention for Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

United States
Mansoura University

Unknown

Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the Prostate

Prostatic Hyperplasia

Egypt
FORUM Pharmaceuticals Inc
Syneos Health; NeuroCog Trials, Inc.

Completed

Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy

Schizophrenia | Impaired Cognition

United States, Australia, Poland, Ukraine, Germany, Spain, Argentina, Serbia, Canada, Singapore, Russian Federation, Brazil, Mexico
Enanta Pharmaceuticals, Inc

Terminated

A Randomized, Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH

Non-Alcoholic Steatohepatitis

United States, Canada, Puerto Rico, United Kingdom, Argentina, Germany

Search clinical trials for: EVP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations